Financial Results for the quarter and year ended on 31/03/2026.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Gujarat Inject Kerala Ltd reported audited standalone results for Q4 and FY26. Total income for FY26 was Rs 3,651.67 Lakhs, up from Rs 1,922.62 Lakhs in FY25, representing approximately 90% revenue growth driven by higher trading sales (Rs 3,632.04 Lakhs vs Rs 1,904.58 Lakhs). Profit after tax increased to Rs 181.41 Lakhs from Rs 101.72 Lakhs, a growth of about 78%. EPS improved from Rs 0.70 to Rs 1.24 per share. Operating cash flow turned strongly positive at Rs 2,122.01 Lakhs compared to negative Rs 352.20 Lakhs in the prior year. The statutory auditors issued an unmodified (clean) opinion on the financial statements. Note 9 mentions figures for the previous period have been restated/regrouped where necessary.
The company showed strong year-on-year improvement with near-doubling of revenue and significant PAT growth. Positive operating cash flow and clean audit opinion are positive indicators for shareholders. However, the company still has negative other equity (reserves of Rs -280.50 Lakhs) which warrants monitoring.